Financial Times Quotes Zain Rizvi on Vaccine IP Waiver

By Kiran Stacey

“The waiver was a huge step, but technology transfer needs to be next,” said Zain Rizvi, a researcher at Public Citizen — one of the groups which led the campaign in favour of an IP waiver for vaccines. “The president needs to deploy all the authority and force of his position to make this happen.”

Read the full story here.